|

Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS

RECRUITINGSponsored by Lithuanian University of Health Sciences
Actively Recruiting
SponsorLithuanian University of Health Sciences
Started2023-12-11
Est. completion2026-12-11
Eligibility
Age18 Years – 65 Years

Summary

This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.

Eligibility

Age: 18 Years – 65 Years
Inclusion Criteria:

* age 18 - 65 years old;
* Diagnosis of F20, F25 or F21 according to ICD-10;
* Signed informed consent form.

Exclusion Criteria:

* Age younger than 18 or older than 65 years old;
* Did not sign the informed consent form;
* Legally inactive person
* Patients with a comorbid or primary diagnosis of mental retardation according to ICD-10 (F70 - F79);
* Patients with a comorbid or primary diagnosis of mental and behavioural disorders due to psychoactive substance use (F10 - F19)
* Patients with a comorbid of primary diagnosis of organic, including symptomatic, mental disorders (F00 - F09)

Conditions5

Cognitive DeficitDepressionDepressive Symptoms Due to Primary Psychotic Disorder (Diagnosis)Negative Symptoms in SchizophreniaSchizophrenia

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.